{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:21:47Z","timestamp":1786980107372,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T00:00:00Z","timestamp":1488844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["21632"],"award-info":[{"award-number":["21632"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00404-017-4317-9","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T05:56:27Z","timestamp":1488866187000},"page":"1041-1050","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients"],"prefix":"10.1007","volume":"295","author":[{"given":"Saeid","family":"Nekoonam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Naji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam Shabani","family":"Nashtaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keywan","family":"Mortezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Koruji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leili","family":"Safdarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fardin","family":"Amidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,7]]},"reference":[{"key":"4317_CR1","doi-asserted-by":"publisher","unstructured":"G\u0142uszak O, Stopi\u0144ska-G\u0142uszak U, Glinicki P, Kapu\u015bci\u0144ska R, Snochowska H, Zgliczy\u0144ski W, D\u0119bski R (2012) Phenotype and metabolic disorders in polycystic ovary syndrome. ISRN Endocrinol 2012. doi: 10.5402\/2012\/569862","DOI":"10.5402\/2012\/569862"},{"issue":"1","key":"4317_CR2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/GRF.0b013e31802f351b","volume":"50","author":"B Trivax","year":"2007","unstructured":"Trivax B, Azziz R (2007) Diagnosis of polycystic ovary syndrome. Clin Obstet Gynecol 50(1):168\u2013177","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"4317_CR3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.mcna.2014.09.003","volume":"99","author":"S Trikudanathan","year":"2015","unstructured":"Trikudanathan S (2015) Polycystic ovarian syndrome. Med Clin North Am 99(1):221\u2013235","journal-title":"Med Clin North Am"},{"issue":"1","key":"4317_CR4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mce.2012.07.011","volume":"373","author":"RJ Chang","year":"2013","unstructured":"Chang RJ, Cook-Andersen H (2013) Disordered follicle development. Mol Cell Endocrinol 373(1):51\u201360","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"4317_CR5","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/humrep\/deq078","volume":"25","author":"F Qu","year":"2010","unstructured":"Qu F, Wang F-F, Lu X-E, Dong M-Y, Sheng J-Z, Lv P-P, Ding G-L, Shi B-W, Zhang D, Huang H-F (2010) Altered aquaporin expression in women with polycystic ovary syndrome: hyperandrogenism in follicular fluid inhibits aquaporin-9 in granulosa cells through the phosphatidylinositol 3-kinase pathway. Hum Reprod 25(6):1441\u20131450","journal-title":"Hum Reprod"},{"issue":"8","key":"4317_CR6","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1210\/jc.2005-2693","volume":"91","author":"T Sir-Petermann","year":"2006","unstructured":"Sir-Petermann T, Codner E, Maliqueo M, Echibur\u00fa B, Hitschfeld C, Crisosto N, P\u00e9rez-Bravo F, Recabarren SE, Cassorla F (2006) Increased anti-Mullerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 91(8):3105\u20133109","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"4317_CR7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humupd\/dmh010","volume":"10","author":"S Jonard","year":"2004","unstructured":"Jonard S, Dewailly D (2004) The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 10(2):107\u2013117","journal-title":"Hum Reprod Update"},{"issue":"7","key":"4317_CR8","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/humrep\/dep049","volume":"24","author":"R Homburg","year":"2009","unstructured":"Homburg R (2009) Androgen circle of polycystic ovary syndrome. Hum Reprod 24(7):1548\u20131555","journal-title":"Hum Reprod"},{"issue":"3","key":"4317_CR9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1530\/EJE-09-0741","volume":"162","author":"JH Barth","year":"2010","unstructured":"Barth JH, Field HP, Yasmin E, Balen AH (2010) Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography\u2013tandem mass spectrometry and analysis by receiver operator characteristic plots. Eur J Endocrinol 162(3):611\u2013615","journal-title":"Eur J Endocrinol"},{"issue":"15","key":"4317_CR10","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1073\/pnas.1418216112","volume":"112","author":"F Wang","year":"2015","unstructured":"Wang F, Pan J, Liu Y, Meng Q, Lv P, Qu F, Ding G-L, Klausen C, Leung PC, Chan HC (2015) Alternative splicing of the androgen receptor in polycystic ovary syndrome. Proc Natl Acad Sci USA 112(15):4743\u20134748","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"4317_CR11","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/en.2009-0751","volume":"151","author":"J-L Yang","year":"2010","unstructured":"Yang J-L, Zhang C-P, Li L, Huang L, Ji S-Y, Lu C-L, Fan C-H, Cai H, Ren Y, Hu Z-Y (2010) Testosterone induces redistribution of forkhead box-3a and down-regulation of growth and differentiation factor 9 messenger ribonucleic acid expression at early stage of mouse folliculogenesis. Endocrinology 151(2):774\u2013782","journal-title":"Endocrinology"},{"issue":"1","key":"4317_CR12","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1146\/annurev.biochem.68.1.965","volume":"68","author":"TO Chan","year":"1999","unstructured":"Chan TO, Rittenhouse SE, Tsichlis PN (1999) AKT\/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem 68(1):965\u20131014","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"4317_CR13","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1530\/JME-14-0220","volume":"53","author":"A Makker","year":"2014","unstructured":"Makker A, Goel MM, Mahdi AA (2014) PI3K\/PTEN\/Akt and TSC\/mTOR signaling pathways, ovarian dysfunction, and infertility: an update. J Mol Endocrinol 53(3):R103\u2013R118","journal-title":"J Mol Endocrinol"},{"issue":"12","key":"4317_CR14","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.2337\/dc08-0532","volume":"31","author":"MO Goodarzi","year":"2008","unstructured":"Goodarzi MO, Jones MR, Chen Y-DI, Azziz R (2008) First evidence of genetic association between AKT2 and polycystic ovary syndrome. Diabetes Care 31(12):2284\u20132287","journal-title":"Diabetes Care"},{"issue":"1","key":"4317_CR15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1432-1327.1999.00774.x","volume":"265","author":"S Masure","year":"1999","unstructured":"Masure S, Haefner B, Wesselink JJ, Hoefnagel E, Mortier E, Verhasselt P, Tuytelaars A, Gordon R, Richardson A (1999) Molecular cloning, expression and characterization of the human serine\/threonine kinase Akt-3. Eur J Biochem 265(1):353\u2013360","journal-title":"Eur J Biochem"},{"issue":"10\u201312","key":"4317_CR16","first-page":"809","volume":"56","author":"S Cecconi","year":"2013","unstructured":"Cecconi S, Mauro A, Cellini V, Patacchiola F (2013) The role of Akt signalling in the mammalian ovary. Int J Dev Biol 56(10\u201312):809\u2013817","journal-title":"Int J Dev Biol"},{"issue":"3","key":"4317_CR17","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1530\/ERC-12-0394","volume":"20","author":"RL Bitting","year":"2013","unstructured":"Bitting RL, Armstrong AJ (2013) Targeting the PI3K\/Akt\/mTOR pathway in castration-resistant prostate cancer. Endocr Relat Cancer 20(3):R83\u2013R99","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"4317_CR18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1042\/bj20020585","volume":"366","author":"M Manin","year":"2002","unstructured":"Manin M, Baron S, Goossens K, Beaudoin C, Claude J, Veyssiere G, Verhoeven G, Morel L (2002) Androgen receptor expression is regulated by the phosphoinositide 3-kinase\/Akt pathway in normal and tumoral epithelial cells. Biochem J 366(3):729\u2013736","journal-title":"Biochem J"},{"issue":"5","key":"4317_CR19","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/humrep\/dep019","volume":"24","author":"JJ Kim","year":"2009","unstructured":"Kim JJ, Choi YM, Hong MA, Hwang SS, Yoon SH, Chae SJ, Jee BC, Ku SY, Kim JG, Moon SY (2009) Phosphatidylinositol 3-kinase p85\u03b1 regulatory subunit gene Met326Ile polymorphism in women with polycystic ovary syndrome. Hum Reprod 24(5):1184\u20131190","journal-title":"Hum Reprod"},{"key":"4317_CR20","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus\u00a0Workshop Group (2004) Revised 2003 consensus on diagnostic\u00a0criteria and long-term health risks related to polycystic\u00a0ovary syndrome. Fertil Steril 81(1):19\u201325","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"issue":"11","key":"4317_CR21","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/humrep\/deu242","volume":"29","author":"D Dewailly","year":"2014","unstructured":"Dewailly D, Alebi\u0107 M\u0160, Duhamel A, Stojanovi\u0107 N (2014) Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles. Hum Reprod 29(11):2536\u20132543","journal-title":"Hum Reprod"},{"issue":"6","key":"4317_CR22","first-page":"430","volume":"52","author":"M Aghahosseini","year":"2014","unstructured":"Aghahosseini M, Aleyasin A, Yekehtaz H, Kashani L (2014) Low-dose human chorionic gonadotropin adjunct to an antagonist protocol in assisted reproductive technology: a Randomized Trial Study. Acta Med Iran 52(6):430\u2013437","journal-title":"Acta Med Iran"},{"issue":"1","key":"4317_CR23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1210\/jc.2002-020788","volume":"88","author":"FP Hohmann","year":"2003","unstructured":"Hohmann FP, Macklon NS, Fauser BC (2003) A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocrinol Metab 88(1):166\u2013173","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"4317_CR24","doi-asserted-by":"crossref","first-page":"e7333","DOI":"10.1371\/journal.pone.0007333","volume":"4","author":"LP Smith","year":"2009","unstructured":"Smith LP, Nierstenhoefer M, Yoo SW, Penzias AS, Tobiasch E, Usheva A (2009) The bile acid synthesis pathway is present and functional in the human ovary. PloS One 4(10):e7333","journal-title":"PloS One"},{"issue":"11","key":"4317_CR25","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1210\/jc.2008-1231","volume":"93","author":"S Catteau-Jonard","year":"2008","unstructured":"Catteau-Jonard S, Jamin SP, Leclerc A, Gonzal\u00e8s J, Dewailly D, di Clemente N (2008) Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome. J Clin Endocrinol Metab 93(11):4456\u20134461","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"4317_CR26","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/humrep\/des096","volume":"27","author":"H Ferrero","year":"2012","unstructured":"Ferrero H, Delgado-Rosas F, Garcia-Pascual CM, Monterde M, Zimmermann RC, Sim\u00f3n C, Pellicer A, G\u00f3mez R (2012) Efficiency and purity provided by the existing methods for the isolation of luteinized granulosa cells: a comparative study. Hum Reprod 27(6):1781\u20131789","journal-title":"Hum Reprod"},{"issue":"1","key":"4317_CR27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00404-016-4068-z","volume":"294","author":"S Mikaeili","year":"2016","unstructured":"Mikaeili S, Rashidi BH, Safa M, Najafi A, Sobhani A, Asadi E, Abbasi M (2016) Altered FoxO3 expression and apoptosis in granulosa cells of women with polycystic ovary syndrome. Arch Gynecol Obstet 294(1):185\u2013192","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"4317_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12958-015-0134-9","volume":"13","author":"A Dumont","year":"2015","unstructured":"Dumont A, Robin G, Catteau-Jonard S, Dewailly D (2015) Role of Anti-M\u00fcllerian hormone in pathophysiology, diagnosis and treatment of polycystic ovary syndrome: a review. Reprod Biol Endocrinol 13(1):1","journal-title":"Reprod Biol Endocrinol"},{"issue":"3","key":"4317_CR29","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2265.2007.03053.x","volume":"68","author":"L Cho","year":"2008","unstructured":"Cho L, Kilpatrick E, Jayagopal V, Diver M, Atkin S (2008) Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia. Clin Endocrinol (Oxf) 68(3):390\u2013394","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"4317_CR30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA (2016) The pathogenesis of polycystic ovary syndrome (PCOS). Endocr Rev 37(5):467\u2013520","journal-title":"Endocr Rev"},{"key":"4317_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/1933719116667606","author":"T Li","year":"2016","unstructured":"Li T, Mo H, Chen W, Li L, Xiao Y, Zhang J, Li X, Lu Y (2016) Role of the PI3K-Akt signaling pathway in the pathogenesis of polycystic ovary syndrome. Reprod Sci doi: 10.1177\/1933719116667606 (epub ahead of print)","journal-title":"Reprod Sci"},{"issue":"1","key":"4317_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7827-7-102","volume":"7","author":"SL Lin","year":"2009","unstructured":"Lin SL, Yan LY, Liang XW, Wang ZB, Wang ZY, Qiao J, Schatten H, Sun QY (2009) A novel variant of ER-alpha, ER-alpha36 mediates testosterone-stimulated ERK and Akt activation in endometrial cancer Hec1A cells. Reprod Biol Endocrinol 7(1):1. doi: 10.1186\/1477-7827-7-102","journal-title":"Reprod Biol Endocrinol"},{"issue":"11","key":"4317_CR33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10815-007-9156-3","volume":"24","author":"M Goto","year":"2007","unstructured":"Goto M, Iwase A, Ando H, Kurotsuchi S, Harata T, Kikkawa F (2007) PTEN and Akt expression during growth of human ovarian follicles. J Assist Reprod Genet 24(11):541\u2013546","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"4317_CR34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/09513590.2011.583955","volume":"28","author":"A Makker","year":"2012","unstructured":"Makker A, Goel MM, Das V, Agarwal A (2012) PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: an update. Gynecol Endocrinol 28(3):175\u2013181","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"4317_CR35","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00404-015-3742-x","volume":"292","author":"D Wuerkenbieke","year":"2015","unstructured":"Wuerkenbieke D, Wang J, Li Y, Ma C (2015) miRNA-150 downregulation promotes pertuzumab resistance in ovarian cancer cells via AKT activation. Arch Gynecol Obstet 292(5):1109\u20131116","journal-title":"Arch Gynecol Obstet"},{"issue":"7","key":"4317_CR36","doi-asserted-by":"publisher","first-page":"e2297","DOI":"10.1038\/cddis.2016.207","volume":"7","author":"G Hua","year":"2016","unstructured":"Hua G, He C, Lv X, Fan L, Wang C, Remmenga S, Rodabaugh K, Yang L, Lele S, Yang P (2016) The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription. Cell Death Dis 7(7):e2297. doi: 10.1038\/cddis.2016.207","journal-title":"Cell Death Dis"},{"issue":"3","key":"4317_CR37","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1242\/dmm.008136","volume":"5","author":"DF Restuccia","year":"2012","unstructured":"Restuccia DF, Hynx D, Hemmings BA (2012) Loss of PKB\u03b2\/Akt2 predisposes mice to ovarian cyst formation and increases the severity of polycystic ovary formation in vivo. Dis Model Mech 5(3):403\u2013411","journal-title":"Dis Model Mech"},{"issue":"5712","key":"4317_CR38","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","volume":"307","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex. Science 307(5712):1098\u20131101","journal-title":"Science"},{"issue":"5","key":"4317_CR39","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.fertnstert.2008.02.091","volume":"89","author":"AA Bremer","year":"2008","unstructured":"Bremer AA, Miller WL (2008) The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance. Fertil Steril 89(5):1039\u20131048","journal-title":"Fertil Steril"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-017-4317-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-017-4317-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-017-4317-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T09:10:47Z","timestamp":1601716247000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-017-4317-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,7]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["4317"],"URL":"https:\/\/doi.org\/10.1007\/s00404-017-4317-9","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,7]]}}}